Targeting host lipogenesis with a diarylamide inhibitor disrupts SARS-CoV-2 replication. (linkinghub.elsevier.com)

Authors: Zhang X … Peng X Journal: iScience Published: 2026-08-06 DOI: https://doi.org/10.1016/j.isci.2026.117111